Dr. Vicktoria Vishnevskia-Dai Ophthalmology & Ocular Oncology

Director - Ocular Oncology , Experience:

Book Appointment

About Doctor

Dr. Victoria Vishnevskia-Dai is a leading, world- renowned specialist in the field of ocular oncology. With her vast experience and top expertise Dr.  Vishnevskia-Dai treats patients from all over the world using the most innovative and progressive treatments available world-wide.

Membership In Professional Societies

1998-Present                 The Israel Ophthalmology Society

1999-Present                 The Israel Society for eye vision and Research (ISEVR)

2003-Present                 The American Academy of Ophthalmology (AAO)

2003-Present                 The International Society of Ocular Oncology (ISOO)

2004-Present                 Ocular Oncology Group (OOG)

2013-Present                 International Society for Genetic Eye Diseases & Retinoblastoma ISGEDR

2014-Present                 European retinoblastoma society ( EU RETINO )

2014-Present                 International Ocular Inflammation Society (IOIS)

               Leading role in Professional Societies

2015-Present                 Secretary general of the Israeli Ophthalmology Society (IOS)

2016-2017                     A member of the organizing committee of the 6 annual IOS meeting

2017-2018                     A member of the organizing committee of the 7 annual IOS meeting

2018-present                 A member of the organizing committee of the 8 annual IOS meeting

Mar 2017-Present         A member of the organizing committee of the bi-Anal meeting of the International Society of Ocular Oncology (ISOO) 2019 Los Angeles

Mar 2017-Present         Elected chair of the 2020 annual Ocular Oncology Group (OOG) meeting – Tel Aviv

2018- Present               Head of the Israli Ocular Oncology Group

Editorial Board:

2014-present                 Chief Editor “Eye Update” a review journal in ophthalmology.


Jan 2017-present           Chief Editor of the Israeli ophthalmological Society Journal (IOS)

  • Senior Ophthalmologist, Director of the Ocular Oncology and Inflammatory eye diseases service.
  • Ocular oncology and inflammatory eye diseases Consultant for the Pediatric oncology department, Oncology institute and immunology institute
  • Senior Lecturer, Ophthalmology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
  • Head of the clinical forum, Ophthalmology, Sackler Faculty of Medicine, Tell-Aviv University, Israel


Sheba Hospital, Tel Aviv, Israel


  • Ocular Oncology
  • Autoimmune Eye Diseases
  • Tuberous sclerosis TS
  • Retinoblastoma
  • Ocular melanoma
  • Uveal melanoma

Procedures Performed

  • Ocular Oncology Treatment
  • Autoimmune Eye Diseases Treatment
  • Tuberous sclerosis TS Treatment
  • Retinoblastoma Treatment
  • Ocular Melanoma Treatment
  • Uveal Melanoma Treatment

Research & Publications

Subretinal Fluid Optical Density and Spectral-Domain Optical Coherence Tomography Characteristics for the Diagnosis of Circumscribed Choroidal Hemangioma. Zur D, Frenkel S, Leshno A, Iglicki M, Ben-Artzi Cohen N, Khoury A, Martínez Cartier M, Barak A, Moroz I, Loewenstein A, Neudorfer M, Vishnevskia-Dai V.

Herpetic Anterior Uveitis – Analysis of Presumed and PCR Proven Cases. Neumann R, Barequet D, Rosenblatt A, Amer R, Ben-Arie-Weintrob Y, Hareuveni-Blum T, Vishnevskia-Dai V, Raskin E, Blumenfeld O, Shulman S, Sanchez JM, Flores V, Habot-Wilner Z.

Prophylactic exposure of human corneal endothelial cells to Rho-associated kinase inhibitor reduced apoptosis rate after phacoemulsification: Ex vivo study. Achiron A, Feldman A, Karmona L, Avizemer H, Barequet IS, Rosner M, Knyazer B, Bartov E, Burgansky Z, Vishnevskia-Dai V.

Need help? Our team is ready to assist you.

We wish a speedy recovery of your dear and near one.

Start chat
We Are Online! Chat With Us!
Scan the code

Welcome to CancerFax !

CancerFax is a pioneering platform dedicated to connecting individuals facing advanced-stage cancer with groundbreaking cell therapies like CAR T-Cell therapy, Gene therapy, TIL therapy, and clinical trials worldwide.

Let us know what we can do for you.

1) CAR T-Cell therapy
2) Gene therapy
3) Gamma-Delta T Cell therapy
4) TIL therapy
5) NK Cell therapy